Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Obstet Gynecol. 2020 Dec;136(6):1086–1094. doi: 10.1097/AOG.0000000000004166

Table 1.

Selected Demographic Characteristics of Patients With Pregnancies Ending in Stillbirth (n = 795) and Matched Live Births (n=3,180)

Characteristic Stillbirths Live Births P*

Age at delivery (y) 30.6 (14–49) 30.4 (14–46) .01
Maternal age 35 y or older 218 (27.4) 633 (19.9) <.001
Gestational age at prenatal care initiation (wk) 7.5 (5–30) 7.4 (5–37) .59
Maternal comorbidity 108 (13.6) 123 (3.9) <.001
Pregnancy complication 365 (45.9) 218 (6.86) <.001
Gestational age at 1st vaccination (wk) 17.6 (2–39)§ 17.4 (2–39) .64
Tobacco smoking during pregnancy 57 (7.2) 279 (8.8) .002
Nulliparous 238 (29.9) 974 (30.6) .38
History of stillbirth 40 (5.0) 54 (1.7) <.001
Black non-Hispanic 107 (13.5) 234 (7.4) <.001
Prepregnancy obesity 279 (35.1) 584 (18.4) <.001

Data are mean (range) or n (%) unless otherwise specified.

*

P-values calculated by χ2 tests for categorical variables and Wilcoxon median two-sample test for continuous variables.

International Classification of Diseases, Ninth Revision codes for maternal diabetes, systemic lupus erythematosus, thyroid disorders, hypertension, cardiovascular disease cholestasis, renal disease, and sickle cell disease in the 6 months before pregnancy through vaccination date or index date (stillbirth outcome date or reference date for matched control).

International Classification of Diseases, Ninth Revision codes for maternal infections, placental complications, amniotic cavity or membrane problems, fetal growth restriction, maternal trauma, and uterine rupture during current pregnancy and before vaccination date or index date.

§

Vaccinations received in 51.7% of pregnancies ending in stillbirth.

Vaccinations received in 52.9% of pregnancies ending in live birth.